Universität zu Köln

Journal Article

Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur. J. Cancer, 136. S. 52 - 69. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Mus, Liselot M., Lambertz, Irina, Claeys, Shana, Kumps, Candy, Van Loocke, Wouter, Van Neste, Christophe ORCID: 0000-0002-5958-5731, Umapathy, Ganesh, Vaapil, Marica, Bartenhagen, Christoph, Laureys, Genevieve, De Wever, Olivier, Bexell, Daniel, Fischer, Matthias, Hallberg, Bengt, Schulte, Johannes, De Wilde, Bram, Durinck, Kaat, Denecker, Geertrui, De Preter, Katleen and Speleman, Frank (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Sci Rep, 10 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Nunes, Carolina ORCID: 0000-0002-8564-6171, Depestel, Lisa ORCID: 0000-0001-5690-3258, Mus, Liselot, Keller, Kaylee M. ORCID: 0000-0002-3130-7465, Delhaye, Louis ORCID: 0000-0001-8876-7385, Louwagie, Amber ORCID: 0000-0003-1808-6749, Rishfi, Muhammad ORCID: 0000-0002-6386-4485, Whale, Alex, Kara, Neesha, Andrews, Simon R., Dela Cruz, Filemon, You, Daoqi, Siddiquee, Armaan, Cologna, Camila Takeno, De Craemer, Sam, Dolman, Emmy, Bartenhagen, Christoph, De Vloed, Fanny, Sanders, Ellen, Eggermont, Aline, Bekaert, Sarah-Lee ORCID: 0000-0002-4769-3460, Van Loocke, Wouter, Bek, Jan Willem ORCID: 0000-0003-1337-1970, Dewyn, Givani, Loontiens, Siebe ORCID: 0000-0002-4602-4580, Van Isterdael, Gert ORCID: 0000-0001-6626-1316, Decaesteker, Bieke, Tilleman, Laurentijn ORCID: 0000-0001-7584-1179, Van Nieuwerburgh, Filip ORCID: 0000-0001-8815-5485, Vermeirssen, Vanessa, Van Neste, Christophe, Ghesquiere, Bart ORCID: 0000-0003-1547-1705, Goossens, Steven, Eyckerman, Sven, De Preter, Katleen, Fischer, Matthias, Houseley, Jon, Molenaar, Jan, De Wilde, Bram ORCID: 0000-0003-0213-1322, Roberts, Stephen S., Durinck, Kaat ORCID: 0000-0003-1762-5739 and Speleman, Frank (2022). RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. Sci. Adv., 8 (28). WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE. ISSN 2375-2548